Education
About Us
Working with TipRanks
Follow Us
NurExone Biologic (TSE:NRX)
:NRX
NRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.53 - C$0.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)47.31K
Market Cap
C$50.93M
Enterprise ValueC$51.62M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Nov 21, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding61,357,914
10 Day Avg. Volume61,302
30 Day Avg. Volume47,310
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.61Price Target Upside214.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
NurExone Biologic News
NRX FAQ
What was NurExone Biologic’s price range in the past 12 months?
NurExone Biologic lowest stock price was C$0.53 and its highest was C$0.85 in the past 12 months.
What is NurExone Biologic’s market cap?
NurExone Biologic’s market cap is C$50.93M.
When is NurExone Biologic’s upcoming earnings report date?
NurExone Biologic’s upcoming earnings report date is Nov 21, 2025 which is in 79 days.
How were NurExone Biologic’s earnings last quarter?
NurExone Biologic released its earnings results on Aug 27, 2025. The company reported -C$0.033 earnings per share for the quarter, missing the consensus estimate of -C$0.028 by -C$0.006.
Is NurExone Biologic overvalued?
According to Wall Street analysts NurExone Biologic’s price is currently Undervalued.
Does NurExone Biologic pay dividends?
NurExone Biologic does not currently pay dividends.
What is NurExone Biologic’s EPS estimate?
NurExone Biologic’s EPS estimate is -0.03.
How many shares outstanding does NurExone Biologic have?
NurExone Biologic has 61,357,914 shares outstanding.
What happened to NurExone Biologic’s price movement after its last earnings report?
NurExone Biologic reported an EPS of -C$0.033 in its last earnings report, missing expectations of -C$0.028. Following the earnings report the stock price went down -1.205%.
Which hedge fund is a major shareholder of NurExone Biologic?
Currently, no hedge funds are holding shares in TSE:NRX
NurExone Biologic Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$2.61 (214.46% Upside)
C$2.61 (214.46% Upside)
Insider Transactions
Bought Shares
Worth C$2.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.06%
12-Months-Change
Fundamentals
Return on Equity
-314.55%
Trailing 12-Months
Asset Growth
-13.25%
Trailing 12-Months
Company Description
NurExone Biologic
EnerSpar Corp is a Canada based company. Its business is the acquisition, exploration, and development of resource property especially in the field of industrial minerals. Its project includes the Johan Beetz Feldspar property.
Technical Analysis
Rapid Dose Therapeutics Corp
―
Helix BioPharma
―
Microbix Biosystms
―
Defence Therapeutics
―
Thiogenesis Therapeutics Corp
―
Ownership Overview
0.35% Insiders
―
Mutual Funds
― Other Institutional Investors
99.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---